Key terms
About TNDM
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest TNDM news
Today
7:58am ET
Piper Sandler Reaffirms Their Buy Rating on Tandem Diabetes Care (TNDM)
May 08
2:14pm ET
Tandem mobile app ‘recall’ a ‘non-event,’ says Stifel
May 08
2:13pm ET
FDA announces Tandem Diabetes recall of t:connect mobile app
May 06
4:32am ET
Tandem Diabetes price target raised to $55 from $39 at Barclays
May 05
9:45pm ET
Barclays Reaffirms Their Buy Rating on Tandem Diabetes Care (TNDM)
May 03
9:04am ET
Tandem Diabetes price target raised to $50 from $35 at Piper Sandler
May 03
9:00am ET
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Castle Biosciences (CSTL)
May 03
8:18am ET
Tandem Diabetes price target raised to $50 from $45 at Wells Fargo
May 03
8:06am ET
Tandem Diabetes Care (TNDM) Gets a Buy from Piper Sandler
May 03
7:47am ET
Tandem Diabetes price target raised to $45 from $35 at TD Cowen
May 03
6:38am ET
Tandem Diabetes Care: Strong Q1 Performance and Upbeat 2024 Outlook Prompt Buy Rating
May 03
6:26am ET
Tandem Diabetes price target raised to $36 from $28 at Baird
May 02
4:34pm ET
Tandem Diabetes sees Fy24 revenue $868M, consensus $845.5M
May 02
4:33pm ET
Tandem Diabetes sees Q2 revenue $205M, consensus $205.0M
May 02
4:33pm ET
Tandem Diabetes reports Q1 EPS (65c), consensus (76c)
May 02
2:31am ET
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Eli Lilly & Co (LLY)
Apr 29
6:37am ET
Wells upgrades Tandem Diabetes on positive endocrinologist survey
Apr 29
5:20am ET
Tandem Diabetes upgraded to Overweight from Equal Weight at Wells Fargo
Apr 25
6:13am ET
Leerink upgrades Tandem Diabetes to Outperform on attractive risk/reward setup
Apr 25
6:02am ET
Tandem Diabetes upgraded to Outperform from Market Perform at Leerink
Apr 23
8:52am ET
Tandem Diabetes price target raised to $40 from $37 at Stifel
Apr 03
5:53am ET
Tandem Diabetes price target raised to $38 from $31 at Citi
Apr 02
9:00am ET
Analysts Are Bullish on These Healthcare Stocks: Tandem Diabetes Care (TNDM), Apyx Medical (APYX)
Mar 25
5:14pm ET
Tandem Diabetes upgraded to Buy at Stifel on strong Mobi adoption
Mar 25
5:06pm ET
Tandem Diabetes upgraded to Buy from Hold at Stifel
Mar 15
7:04am ET
Tandem Diabetes price target raised to $31 from $25 at Citi
Mar 06
8:55am ET
Tandem Diabetes Care (TNDM) Gets a Buy from Lake Street
Mar 05
8:47am ET
Craig-Hallum Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM)
Mar 04
6:29pm ET
Tandem Diabetes announces private placement of $250M in convertible senior notes
Feb 28
11:14am ET
Tandem Diabetes (NASDAQ:TNDM): Investors Look to Innovation to Drive the Stock Higher
Feb 25
11:28pm ET
Tandem Diabetes Care Holds Steady: A Cautious Outlook Amidst Growth and Competitive Uncertainty
No recent press releases are available for TNDM
TNDM Financials
Key terms
Ad Feedback
TNDM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TNDM Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
